66th Annual Meeting of the Japanese Society of Neurology
Advanced Search

Session Details

Oral Session

[O-15]Oral Session 15　Headache

Thu. May 22, 2025 9:45 AM - 10:45 AM JST
Thu. May 22, 2025 12:45 AM - 1:45 AM UTC
第05会場(大阪国際会議場10F 会議室1009)
Chairs: Takao Takeshima（Department of Neurology, Tominaga Hospital, Japan）, Kazumasa Saigoh（Department of Clinical Genetics, Kindai University Hospital, Japan）

[O-15-1]The CGRP Monoclonal Antibody Treatment Affects Brain Volume and Magnetic Susceptibility in Migraine

Yuya Kano1,2, Yuto Uchida2,3, Hirohito Kan4, Keita Sakurai5, Haruto Shibata2,6, Mitsuharu Yamamoto7, Koji Takada1, Takao Takeshima8, Noriyuki Matsukawa2 (1.Department of Neurology, Toyokawa City Hospital, Japan, 2.Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Japan, 3.Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, USA, 4.Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Japan, 5.Department of Radiology, National Center for Geriatrics and Gerontology, Japan, 6.Department of Neurology, Nagoya City University East Medical Center, Japan, 7.Department of Neurosurgery, Toyokawa City Hospital, Japan, 8.Department of Neurology, Tominaga Hospital, Japan)

[O-15-2]Long-term efficacy of 675-mg Fremanezumab on Chronic, Episodic, and Medication-Overuse Headaches

Shohei Yoshida, Noboru Imai, Jun Kamimura, Asami Moriya, Nobuyasu Yagi, Rieko Suzuki, Takashi Konishi, Masahiro Serizawa (Japanese Red Cross Society Shizuoka Hospital, Japan)

[O-15-3]withdrawn

[O-15-4]TRP channel may be the key role for sensing the atmospheric pressure change inducing migraine

Hitoshi Maeda, Shunichi Kuwana (Department of Rehabilitation, Uekusa Gakuen University, Japan)
Back to Category List